Carregant...
Tipus de document
AltresVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/206265
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
IntroductionMethicillin-resistant and -susceptible Staphylococcus aureus (MRSA/MSSA) infections are a major global health-care problem. Bacteremia with S. aureus exhibits high rates of morbidity and mortality and can cause complicated infections such as infective endocarditis (IE). The emerging resistance profile of S. aureus is worrisome, and several international agencies have appealed for new treatment approaches to be developed.Areas coveredDaptomycin presents a rapid bactericidal effect against MRSA and has been considered at least as effective as vancomycin in treating MRSA bacteremia. However, therapy failure is often related to deep-seated infections, e.g. endocarditis, with high bacterial inocula and daptomycin regimens S. aureus infections have limitations in monotherapy. Daptomycin in combination with other antibiotics, e.g. fosfomycin, may be effective in improving clinical outcomes in patients with MRSA IE.Expert opinionExploring therapeutic combinations has shown fosfomycin to have a unique mechanism of action and to be the most effective option in preventing the onset of resistance to and optimizing the efficacy of daptomycin, suggesting the synergistic combination of fosfomycin with daptomycin is a useful alternative treatment option for MSSA or MRSA IE.
Matèries
Matèries (anglès)
Citació
Citació
GARCIA DE LA MÀRIA, Cristina, CAÑAS, María alexandra, FERNÁNDEZ PITTOL, Mariana, DAHL, Anders, GARCÍA GONZÁLEZ, Javier, HERNÁNDEZ MENESES, Marta, CUERVO REQUENA, Guillermo, MORENO, Asunción, MIRÓ MEDA, José m. (josé maría), MARCO, Francesc. Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin. _Expert Review Of Anti-Infective Therapy_. 2023. Vol. 21, núm. 3, pàgs. 281-293. [consulta: 23 de gener de 2026]. ISSN: 1744-8336. [Disponible a: https://hdl.handle.net/2445/206265]